Free shipping on all orders over $ 500

PAR-4 Agonist Peptide, amide TFA

Cat. No. M14049

All AbMole products are for research use only, cannot be used for human consumption.

PAR-4 Agonist Peptide, amide TFA Structure
Synonym:

PAR-4-AP TFA; AY-NH2 TFA

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

PAR-4 Agonist Peptide, amide TFA (PAR-4-AP TFA; AY-NH2 TFA) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist.

Chemical Information
Molecular Weight 794.82
CAS Number 1228078-65-6
Solubility (25°C) DMSO ≥ 150 mg/mL
Storage -20°C, dry, sealed
Related PAR Products
ML161

Parmodulin 2 (ML161) is an allosteric inhibitor of PAR1 with IC50 of 0.26 μM.

Vorapaxar

Vorapaxar (SCH 530348) is a potent and orally active thrombin receptor (PAR-1) antagonist with Ki of 8.1 nM.

Vorapaxar Sulfate

Vorapaxar is a first-in-class, potent and orally-active protease-activated receptor 1 (PAR-1) antagonist that blocks thrombin-mediated platelet activation without interfering with thrombin-mediated fibrin deposition.

ML354

ML354 is a potent and selective PAR4 (protease activated receptor-4) antagonist.

PAR-4 (1-6) (human)

PAR-4 (1-6) (human) is an N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: PAR-4 Agonist Peptide, amide TFA, PAR-4-AP TFA; AY-NH2 TFA supplier, PAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.